Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial
NEPHROLOGY DIALYSIS TRANSPLANTATION, vol.19, no.12, pp.3137-3139, 2004 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 19 Issue: 12
- Publication Date: 2004
- Doi Number: 10.1093/ndt/gfh496
- Journal Name: NEPHROLOGY DIALYSIS TRANSPLANTATION
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.3137-3139
- Erciyes University Affiliated: No
Abstract
Background. Uraemic pruritus is a common and distressing symptom in patients on haemodialysis for chronic renal failure. Gabapentin is an anticonvulsant that alleviates neuropathic pain. We conducted a double-blind. placebo-controlled, crossover study to assess its effectiveness against renal itch.